2-piperidone has been researched along with cocaine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoplight, BJ; Neumaier, JF; Vincow, ES | 1 |
| Adams, MD; Bastle, RM; Brunwasser, SJ; Der-Ghazarian, T; Harder, BG; Neisewander, JL; Peartree, NA; Pentkowski, NS; Yanamandra, K | 1 |
| Hall, FS; Hen, R; Sora, I; Uhl, GR | 1 |
3 other study(ies) available for 2-piperidone and cocaine
| Article | Year |
|---|---|
The effects of SB 224289 on anxiety and cocaine-related behaviors in a novel object task.
Topics: Animals; Anxiety; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Environment; Male; Motor Activity; Piperidones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Serotonin Antagonists; Spiro Compounds; Stimulation, Chemical | 2005 |
Pharmacological evidence for an abstinence-induced switch in 5-HT1B receptor modulation of cocaine self-administration and cocaine-seeking behavior.
Topics: Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Piperidones; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Reinforcement Schedule; Self Administration; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Spiro Compounds; Substance Withdrawal Syndrome; Time Factors | 2014 |
Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Locomotion; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Piperidones; Receptor, Serotonin, 5-HT1B; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Spiro Compounds | 2014 |